International Journal of Gynecology & Obstetrics · 2010 · 97 citations · 7 references
MedicineMaternal HealthObstetricsMaternal-fetal MedicineReproductive HealthReproductive MedicineMaternal ComplicationsMaternal Medical ConditionsMaternal SafetyPostpartum ComplicationsPregnancySafe AbortionBirthing Services AdministrationMaternal Patient SafetyMisoprostol TherapyMisoprostol Use In AbortionOperations Research ModelsUterotonic Drug UseUterotonic Prophylaxis
OBJECTIVE: To determine feasibility of community-based distribution of misoprostol for preventing postpartum hemorrhage (PPH) to pregnant woman through community volunteers working under government health services. METHODS: Implemented in one district in Nepal. The primary measure of performance was uterotonic protection after childbirth, measured using pre- and postintervention surveys (28 clusters, each with 30 households). Maternal deaths were ascertained through systematic health facility and community-based surveillance; causes of death were assigned based on verbal autopsy. RESULTS: Of 840 postintervention survey respondents, 73.2% received misoprostol. The standardized proportion of vaginal deliveries protected by a uterotonic rose from 11.6% to 74.2%. Those experiencing the largest gains were the poor, the illiterate, and those living in remote areas. CONCLUSION: Community-based distribution of misoprostol for PPH prevention can be successfully implemented under government health services in a low-resource, geographically challenging setting, resulting in much increased population-level protection against PPH, with particularly large gains among the disadvantaged.
7
Oral Misoprostol for the Third Stage of Labor
Eray Çalışkan, Berna Dilbaz, M. Mutlu Meydanli et al. · Obstetrics and Gynecology · 2003 · 59 citations